✦ LIBER ✦

An economic analysis of bevacizumab in recurrent treatment of ovarian cancer

✍ Scribed by J. Chan; B. Monk; K. Fuh; R. Urban; L. Hu; A. Caughey; X. Yu

Book ID: 113962796
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 127 KB
Volume: 120
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.12.073

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An economic analysis of bevacizumab in t

An economic analysis of bevacizumab in treatment of cervical cancer

✍ Geisler, J.P.; Walter, A.; Manahan, K.J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Bevacizumab in the Treatment of Ovarian

Bevacizumab in the Treatment of Ovarian Cancer

✍ Florian Heitz, Philipp Harter, Jana Barinoff, Bianca Beutel, Paevi Kannisto, Jac 📂 Article 📅 2012 🏛 Springer Healthcare Communications 🌐 English ⚖ 963 KB

Combination gemcitabine, platinum, and b

Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer

✍ Debra L. Richardson; Floor J. Backes; Leigh G. Seamon; Vanna Zanagnolo; David M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 205 KB

PCN75 Economic Evaluation of Bevacizumab

PCN75 Economic Evaluation of Bevacizumab for the Treatment of Advanced Ovarian Cancer in Mexico

✍ Lechuga, D.; Alva, M.; Carlos, F. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Incorporation of Bevacizumab in the Prim

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

✍ Burger, Robert A.; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Monk, 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 690 KB

Bladder perforation in a patient with re

Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab

✍ Nisha Bansal; Mitchell Hoffman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 157 KB